| The transcription factor PAX8 promotes angiogenesis in ovarian cancer through interaction with SOX17 D Chaves-Moreira, MA Mitchell, C Arruza, P Rawat, S Sidoli, R Nameki, ... Science signaling 15 (728), eabm2496, 2022 | 35 | 2022 |
| A highly sensitive ISFET using pH-to-current conversion for real-time DNA sequencing MM Uzzal, P Zarkesh-Ha, JS Edwards, E Coelho, P Rawat 2014 27th IEEE International System-on-Chip Conference (SOCC), 410-414, 2014 | 14 | 2014 |
| PAX8 orchestrates an angiogenic program through interaction with SOX17 D Chaves-Moreira, MA Mitchell, C Arruza, P Rawat, S Sidoli, R Nameki, ... BioRxiv, 2020.09. 09.290387, 2020 | 8 | 2020 |
| Norepinephrine induces anoikis resistance in high-grade serous ovarian cancer precursor cells HD Reavis, SM Gysler, GB McKenney, M Knarr, HJ Lusk, P Rawat, ... JCI insight 9 (5), 2024 | 7 | 2024 |
| H2Bub1 loss is an early contributor to clear cell ovarian cancer progression AJ Ferrari, P Rawat, HS Rendulich, AV Annapragada, Y Kinose, X Zhang, ... JCI insight 8 (12), 2023 | 2 | 2023 |
| Repurposing colforsin daropate to treat MYC-driven high-grade serous ovarian carcinomas MJ Knarr, J Moon, P Rawat, A DiFeo, DSB Hoon, R Drapkin Cancer Therapy 17 (863), https://doi.org/10.1126/scisignal.ado830, 2024 | | 2024 |
| Abstract PR010: TRPV1+ sensory innervation as a novel driver of ovarian cancer progression M Knarr, K Cummins, D Racordon, H Reavis, T Lippert, R Hausler, ... Cancer Research 84 (22_Supplement), PR010-PR010, 2024 | | 2024 |
| Microglia replacement by ER-Hoxb8 conditionally immortalized macrophages provides insight into Aicardi-Goutières Syndrome neuropathology KM Nemec, G Uy, VS Chaluvadi, FS Purnell, B Elfayoumi, CAO Brien, ... Biorxiv, 2024.09.18.613629, 2024 | | 2024 |
| Sensory innervation as a novel driver of ovarian cancer progression M Knarr, K Cummins, D Racordon, H Reavis, T Lippert, R Hausler, ... Cancer Research 84 (6_Supplement), 2922-2922, 2024 | | 2024 |
| Abstract A088: Tumor innervation as a novel driver of ovarian cancer progression M Knarr, H Reavis, T Lippert, P Rawat, P Vermeer, R Drapkin Cancer Research 84 (5_Supplement_2), A088-A088, 2024 | | 2024 |
| Next generation sequencing technologies for real-time genotyping and targeted sequencing for precision medicine P Rawat University Of New Mexico, 2017 | | 2017 |
Ronny Drapkin, MD, PhDUniversity of Pennsylvania, Perelman School of Medicine在 pennmedicine.upenn.edu 的电子邮件经过验证
